Qube Research & Technologies (QRT)’s LB Pharmaceuticals LBRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LBRX Stock Details LBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.27M	Buy	+32,997	New	+$1.36M	﹤0.01%	2518

Other funds holding LBRX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Spruce Street Capital New York $629M AUM 210.46% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Nan Fung Group Holdings Kai Tak, Hong Kong $150M AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LBRX Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in LB Pharmaceuticals (LBRX) in Q3 2026: 32,997 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #2518 among its holdings.

93 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.

Qube Research & Technologies (QRT) held 32,997 shares of LB Pharmaceuticals worth $1.27M as of Q3 2026.
LB Pharmaceuticals was a new Qube Research & Technologies (QRT) position in Q3 2026.
LB Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2518 holding.
93 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.